- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/29 - Parathyroid hormone, i.e. parathormoneParathyroid hormone-related peptides
Patent holdings for IPC class A61K 38/29
Total number of patents in this class: 501
10-year publication summary
|
35
|
39
|
43
|
39
|
39
|
33
|
48
|
36
|
39
|
14
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Ascendis Pharma Bone Diseases A/S | 56 |
37 |
| Radius Health, Inc. | 94 |
36 |
| Entera Bio Ltd. | 50 |
31 |
| Rani Therapeutics, LLC | 193 |
27 |
| MannKind Corporation | 529 |
19 |
| Asahi Kasei Pharma Corporation | 115 |
16 |
| Board of Trustees of the University of Arkansas | 828 |
12 |
| The General Hospital Corporation | 4870 |
9 |
| Purdue Research Foundation | 3916 |
9 |
| National University Corporation Kagawa University | 211 |
9 |
| Ipsen Pharma S.A.S. | 377 |
6 |
| Montefiore Medical Center | 83 |
6 |
| Ochsner Clinic Foundation | 26 |
6 |
| University of Rochester | 1330 |
6 |
| Kindeva Drug Delivery L.P., Kindeva GP II LLC, a Delaware limited liability company | 217 |
6 |
| Amryt Pharmaceuticals, Inc. | 74 |
6 |
| The Kitasato Institute | 152 |
5 |
| Mondobiotech Laboratories AG | 311 |
5 |
| Novartis AG | 10262 |
4 |
| The Regents of the University of Michigan | 4985 |
4 |
| Other owners | 242 |